New FattyCast: Talking with Pelotonia CEO Doug Ulman

03.15.2016 | 11:05 am

A Note from Fatty: If you took the time to fill out the survey I was talking about in my recent posts, thank you. Your feedback has been incredibly helpful, and now I’m working on incorporating it into my plan. I’ll let you know what I’ve learned and plan to do soon.

Doug Ulman is the president and CEO of Pelotonia, an Ohio-based charity that can make the unusual claim that 100% of its rider-raised funds go toward high-risk, high-reward cancer research.

NewImage

But Doug’s history with cancer goes way back, including having his own foundation, being the president of Livestrong during the good and bad times.

Doug was one of the many great people who inspired me to fundraise for important causes, and he’s the one who introduced me to Camp Kesem.

NewImage

Doug doesn’t talk from an abstract place when he talks about cancer. He was diagnosed with cancer about twenty years ago. Or make that diagnoses — Doug was diagnosed with cancer three times in a one-year period. 

It’s been a while since he and I have talked, and I was looking forward to catching up.

In this FattyCast, Doug and I talk about the differences in fundraising for cancer awareness, treatment, and research.

We talk about why fundraisers so frequently center around cycling events.

We talk about things we hate people saying about cancer.

And we talk about regrets and lessons learned at Livestrong after Lance Armstrong was found to be a cheater. 

This is a thoughtful, enlightening episode of the FattyCast. I think you’re going to enjoy it.

on iTunesStitcherFattyCast.com, or on my fattycast.com/rss feed.

Or just listen / download it here:

8 Comments

  1. Comment by John Zanner | 03.15.2016 | 1:56 pm

    Just want to say, as the son of a cancer survivor who lives in Columbus, Peletonia is an A+ organization that is truly remarkable for their impact in the community.

  2. Comment by Ken Koz | 03.16.2016 | 3:52 am

    I live in Dublin, OH and will be doing the 100-mile version of Pelotonia this August with a team of “Cancer Crushers.” It is a fantastic event.

  3. Comment by ow | 03.16.2016 | 8:08 am

    fierce goatee – intimidating yet sophisticated

  4. Comment by Jim | 03.16.2016 | 9:42 am

    Thanks for the podcasts, Fatty. Interesting as always. One bonus is that your podcasts have excellent audio. That is something that cannot be said about most other podcasts I listen to.

    Thank you, Jim! I feel like a real novice in the audio department, but I’m having a ton of fun learning as I go. – FC

  5. Comment by Doug (Way Upstate NY) | 03.17.2016 | 5:33 am

    I really enjoyed that. Both the new and the old.

  6. Comment by Susanne Kondracke | 03.17.2016 | 6:26 am

    Thank you for highlighting PELOTONIA and our tremendous leader Doug Ulman.

  7. Comment by Skye | 03.19.2016 | 5:19 pm

    Dear Fatty,

    I am a pseudo-accountant. I play with numbers and spreadsheets all day. Usually I can use half of my brain to do number things, and the other half can listen to words, and there are several podcasts I can listen to while working. Yours is not one of them though! Your choice of guests and the subject matter are so worth while and interesting that I find I stop typing, stop trying to add numbers, stop trying to work out some bogus logic to solve a problem that can’t be seen- and I just listen. And ultimately, thats a good thing, but it does mean that your very well done podcasts will just have to pile up in my podcast feed for now, because its budget season and my free time is lacking. Maybe you can help me clean the house later, but I’ll have to leave you at home from now on; you can’t come to work with me anymore.

    Well done!

  8. Comment by Shugg McGraw | 03.22.2016 | 6:46 am

    I was engrossed by this – against my expectations.
    I’m not even a pseudo-accountant but, if The James develops a cure for all cancers, say, and the research has been funded entirely by donations, everyone will have access to that cure for free or for the cost of manufacture of the drug?

 

Sorry, the comment form is closed at this time.